Pharmacology > EXAM > NURS 6521N-55 ADVANCED PHARMACOLOGY FINAL EXAM (All)

NURS 6521N-55 ADVANCED PHARMACOLOGY FINAL EXAM

Document Content and Description Below

NURS 6521N-55 ADVANCED PHARMACOLOGY FINAL EXAM • Question 1 1 out of 1 points A 28-year-old woman has completed rituximab therapy for an autoimmune disease. She tells the nurse that she and her husband would like to start a family. The nurse will advise her to Response Feedback: Rituximab is not recommended for use in pregnancy or when women are lactating. The patient should consequently be advised to continue using birth control for the duration of treatment. • Question 2 1 out of 1 points A 45-year-old woman with acute leukemia is going to begin chemotherapy with vincristine. The nurse is aware that vincristine must always be administered Response Feedback : If vincristine is administered as a continuous infusion, a central line should always be used. It is important to prime IV lines for chemotherapy administration with 5% dextrose in water or normal saline, not with vincristine, before administering the drug. The infusion rate, although important, is not as important a factor for vincristine administration as is the need for a central line. • Question 3 1 out of 1 points A patient with chronic heart failure has begun treatment with epoetin alfa, which she will receive in her own home from a home health nurse. The nurse should teach the patient to supplement this treatment with a diet that is high in Response Feedback: Patients receiving epoetin alfa should maintain adequate iron intake, which may aid in the effectiveness of epoetin alfa. Foods high in iron include green leafy vegetables, beans, and organ meats. • Question 4 1 out of 1 points A nurse is administering rituximab to a patient via the IV route. The nurse will set the IV pump at 50 mg/hour for the first half hour of the initial infusion. If there are not apparent reactions after 30 minutes of the infusion, the nurse will increase the dosage every 30 minutes by 50 mg/hour until the maximum infusion rate reaches which of the following? Response Feedback : Infusion-related effects occur in 80% of patients within 30 minutes to 2 hours after the first rituximab infusion, but the severity of most reactions dissipates when the infusion rate is slowed or interrupted. Reactions may be related to dose, so it is advisable not to exceed the maximum infusion rate of 400 mg/hour. • Question 5 1 out of 1 points During ongoing assessment of a patient receiving 5-FU therapy, the nurse finds the patient's platelet count to be 92,000 cells/mm3. The nurse should do which of the following? Response Feedback: The drug should be discontinued if the patient's platelet count is less than 1,00,000 cells/mm3 because it indicates that the patient has developed thrombocytopenia. Increasing the dosage or continuing the therapy with a decreased dosage is not appropriate.

[Show More]

Last updated: 3 years ago

Preview 1 out of 10 pages

Buy Now

Instant download